Literature DB >> 3909370

Diffusion and polymerization determines the insulin absorption from subcutaneous tissue in diabetic patients.

P Hildebrandt, P Sejrsen, S L Nielsen, K Birch, L Sestoft.   

Abstract

In 23 diabetic patients, the disappearance from subcutaneous tissue of 125I-labelled short-acting insulin and of 133Xe (measuring subcutaneous blood flow (SBF] were registered simultaneously. Alterations in the SBF were produced either by orthostatic changes or by application of local heat or cold. The insulin absorption rate was related to the SBF in a curvilinear way with an almost linear relation at SBF below 2-3 ml . (min . 100 g)-1, whereas at SBFs above the value the insulin absorption rate increased less than proportional to SBF. Capillary diffusion capacity of the injected insulin was 0.0145-0.0874 ml . (min . 100 g)-1; indicating that insulin is absorbed in a polymeric form. This was supported by studies of insulin diffusion in agar gel at 37 degrees C, showing that insulin in the normal pharmacological concentration diffuses as a molecule of about 46,000 MW. In conclusion, the absorption of short-acting soluble insulin is curvilinearly related to the SBF. This can be explained by a diffusion-limited transport of insulin in the interstitial space, and increasing transcapillary transport of insulin at increasing blood flow rates caused by recruitment of capillaries, thus increasing exchange surface area and decreasing diffusion distance.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3909370     DOI: 10.1080/00365518509155280

Source DB:  PubMed          Journal:  Scand J Clin Lab Invest        ISSN: 0036-5513            Impact factor:   1.713


  13 in total

1.  Lymphatic absorption is a significant contributor to the subcutaneous bioavailability of insulin in a sheep model.

Authors:  S A Charman; D N McLennan; G A Edwards; C J Porter
Journal:  Pharm Res       Date:  2001-11       Impact factor: 4.200

2.  A comparison of three mathematical models to describe the disappearance curves of subcutaneously injected 125I-labelled insulin.

Authors:  P H De Meijer; F G Russel; H J Van Lier; C A Van Ginneken
Journal:  Br J Clin Pharmacol       Date:  1989-04       Impact factor: 4.335

3.  Modeling absorption kinetics of subcutaneous injected soluble insulin.

Authors:  E Mosekilde; K S Jensen; C Binder; S Pramming; B Thorsteinsson
Journal:  J Pharmacokinet Biopharm       Date:  1989-02

4.  Modeling the acute effects of exercise on insulin kinetics in type 1 diabetes.

Authors:  Spencer Frank; Abdulrahman Jbaily; Ling Hinshaw; Rita Basu; Ananda Basu; Andrew J Szeri
Journal:  J Pharmacokinet Pharmacodyn       Date:  2018-11-03       Impact factor: 2.745

5.  Pharmacokinetic analysis of drug absorption from muscle based on a physiological diffusion model: effect of molecular size on absorption.

Authors:  E Nara; M Masegi; T Hatono; M Hashida
Journal:  Pharm Res       Date:  1992-02       Impact factor: 4.200

6.  Insulin bolus given by sprinkler needle: effect on absorption and glycaemic response to a meal.

Authors:  B Edsberg; D Herly; P Hildebrandt; C Kühl
Journal:  Br Med J (Clin Res Ed)       Date:  1987-05-30

Review 7.  Derivatization with fatty acids in peptide and protein drug discovery.

Authors:  Peter Kurtzhals; Søren Østergaard; Erica Nishimura; Thomas Kjeldsen
Journal:  Nat Rev Drug Discov       Date:  2022-08-24       Impact factor: 112.288

8.  The mechanism of protraction of insulin detemir, a long-acting, acylated analog of human insulin.

Authors:  Svend Havelund; Anne Plum; Ulla Ribel; Ib Jonassen; Aage Vølund; Jan Markussen; Peter Kurtzhals
Journal:  Pharm Res       Date:  2004-08       Impact factor: 4.200

9.  Recombinant DNA derived monomeric insulin analogue: comparison with soluble human insulin in normal subjects.

Authors:  J P Vora; D R Owens; J Dolben; J A Atiea; J D Dean; S Kang; A Burch; J Brange
Journal:  BMJ       Date:  1988-11-12

Review 10.  A Review of the Current Challenges Associated with the Development of an Artificial Pancreas by a Double Subcutaneous Approach.

Authors:  Sverre Christian Christiansen; Anders Lyngvi Fougner; Øyvind Stavdahl; Konstanze Kölle; Reinold Ellingsen; Sven Magnus Carlsen
Journal:  Diabetes Ther       Date:  2017-05-13       Impact factor: 2.945

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.